Grant/GrossMendelsohn, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Grant/GrossMendelsohn, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$715,567
+4.8%
7,0250.0%0.31%
+11.9%
Q2 2023$682,549
+5.3%
7,0250.0%0.28%
-17.1%
Q4 2022$648,337
+17.7%
7,0250.0%0.33%
+12.1%
Q3 2022$551,000
+41.3%
7,025
+50.9%
0.30%
+36.7%
Q2 2022$390,000
-8.5%
4,6540.0%0.22%
+2.3%
Q1 2022$426,0004,6540.21%
Other shareholders
NOVARTIS A G shareholders Q3 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders